Clinical consideration and management of coronavirus disease 2019

• Published in: Zhonghua gan zang bing za zhi Vol. 28; no. 3; p. 222
• Main Authors: Ma, K, Chen, T, Han, M F, Guo, W, Ning, Q
• Format: Journal Article
• Language: Chinese
• Published: China 20-03-2020
• Subjects: Antiviral Agents - therapeutic use; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections - diagnosis; Coronavirus Infections - drug therapy; Coronavirus Infections - epidemiology; Coronavirus Infections - prevention & control; Humans; Pandemics - prevention & control; Pneumonia, Viral - diagnosis; Pneumonia, Viral - drug therapy; Pneumonia, Viral - epidemiology; Pneumonia, Viral - prevention & control; COVID-19; Treatment; Diagnosis; 2019 novel coronavirus
• ISSN: 1007-3418
• DOI: 10.3760/cma.j.cn50113-20200220-00056

Coronavirus disease 2019 (COVID-19) outbreak in Wuhan city, Hubei province in December 2019 and the epidemic so rapidly happened within the whole country and abroad, raising serious problems and urgent concerns, such as: how to control most effectively human-to-human transmission? When does infection rate rise to its peak? What will eventually be the number of infected patients? How to make early diagnosis? What effective antiviral drugs are available? How to use the existing drugs to achieve the best effect? Can available drugs effectively improve the survival rate of critical patients? In view of the above questions, this article now puts forwards the corresponding suggestions and considerations from the perspective of clinical infectious diseases physician.